These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34057286)

  • 1. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.
    Muso E; Sakai S; Ogura Y; Yukawa S; Nishizawa Y; Yorioka N; Saito T; Mune M; Sugiyama S; Iino Y; Hirano T; Hattori M; Watanabe T; Yokoyama H; Sato H; Uchida S; Wada T; Shoji T; Oda H; Mori K; Kimura H; Ito O; Nishiyama A; Maruyama S; Inagi R; Fujimoto S; Tsukamoto T; Suzuki Y; Honda H; Babazono T; Tsuruya K; Yuzawa Y
    Ther Apher Dial; 2022 Feb; 26(1):220-228. PubMed ID: 34057286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
    Muso E; Mune M; Hirano T; Hattori M; Kimura K; Watanabe T; Yokoyama H; Sato H; Uchida S; Wada T; Shoji T; Yuzawa Y; Takemura T; Sugiyama S; Nishizawa Y; Ogahara S; Yorioka N; Sakai S; Ogura Y; Yukawa S; Iino Y; Imai E; Matsuo S; Saito T
    Clin Exp Nephrol; 2015 Jun; 19(3):379-86. PubMed ID: 24934117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on LDL apheresis for nephrotic syndrome.
    Raina R; Krishnappa V
    Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
    Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
    Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
    Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K
    Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome.
    Miyata H; Uno K; Ono T; Yashiro M; Fukatsu A; Kita T; Kimura T; Muso E
    Ther Apher Dial; 2012 Apr; 16(2):189-94. PubMed ID: 22458400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.
    Nakamura T; Kawagoe Y; Ogawa H; Ueda Y; Hara M; Shimada N; Ebihara I; Koide H
    Am J Kidney Dis; 2005 Jan; 45(1):48-53. PubMed ID: 15696443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab-Resistant Nephrotic Syndrome With Successful Induction of Remission by Low-Density Lipoprotein Apheresis.
    Suzuki H; Tsukamoto T; Muso E
    Ther Apher Dial; 2017 Jun; 21(3):295-296. PubMed ID: 28661090
    [No Abstract]   [Full Text] [Related]  

  • 9. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
    Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
    Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis.
    Kamijo Y; Kaneko Y; Ichikawa T; Kobayashi N; Koyama T; Kakegawa T; Kamijo H; Kono K; Minami S; Tanaka N; Arakura H; Hirata M; Higuchi M; Kiyosawa K; Hora K
    Ther Apher; 2002 Dec; 6(6):459-62. PubMed ID: 12460411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
    Muso E; Mune M; Yorioka N; Nishizawa Y; Hirano T; Hattori M; Sugiyama S; Watanabe T; Kimura K; Yokoyama H; Sato H; Saito T
    Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
    Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
    J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
    Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
    Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
    Muso E
    Clin Exp Nephrol; 2014 Apr; 18(2):286-90. PubMed ID: 24535024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
    Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
    Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report.
    Ideura T; Hora K; Kaneko Y; Yamazaki T; Tokunaga S; Shigematsu H; Kiyosawa K
    Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029
    [No Abstract]   [Full Text] [Related]  

  • 20. Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
    Faucher C; Albert C; Beaufils H; Jouanneau C; Dupouet L
    Nephrol Dial Transplant; 1997 May; 12(5):1037-9. PubMed ID: 9175066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.